Home » Newsletters » BioWorld Science

BioWorld Science

March 7, 2012

View Archived Issues

New phosphodiesterase 10A inhibitors discovered

Phase II trial of CTP-499 advances

FluoroPharma Medical plans phase II study of cardiac imaging agent

Icatibant acetate may improve acquired angioedema

New chemokine CCR8 receptor antagonists identified at AstraZeneca

Novel kinase inhibitors developed in Spain

Roche patents new candidate hepatitis C therapies

New renin inhibitors designed in China

Collaborating companies in Japan synthetize novel CKI inhibitors

Advinus Therapeutics announces novel glucokinase activators

Seglin OGA inhibitors show promise in vivo

Madrigal launches new phase I trial of cholesterol-lowering agent

EyeGate Pharma begins phase I trial in anterior scleritis

FDA supports initiation of pivotal DSC-127 trials

EMA grants orphan drug status to Cytokinetics drug in ALS

New Taisho drug has promising pharmacological profile

Novel SYK inhibitor shows potential as asthma therapeutic

Miraculins provides details on FDA's clearance of cholesterol test

Eisai receives complete response letter on Dacogen

Stem cell product set to be assessed in patients with artery disease

FDA approves Surfaxin

AcelRx advances patient-controlled analgesia system to phase III

More encouraging results reported on levomilnacipran in MDD

Michael J. Fox Foundation awards funding to QR Pharma

Abbott to develop companion diagnostic for Merck & Co. anticancer candidate

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...